Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Microsoft
MSFT
|
+$908M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$706M |
| 3 |
Truist Financial
TFC
|
+$462M |
| 4 |
Amazon
AMZN
|
+$348M |
| 5 |
ServiceNow
NOW
|
+$268M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
+$1.15B |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$466M |
| 3 |
VIAB
Viacom Inc. Class B
VIAB
|
+$139M |
| 4 |
Oracle
ORCL
|
+$130M |
| 5 |
Intuitive Surgical
ISRG
|
+$117M |
Sector Composition
| 1 | Technology | 19.82% |
| 2 | Financials | 15.45% |
| 3 | Healthcare | 13.87% |
| 4 | Consumer Discretionary | 9.9% |
| 5 | Industrials | 9.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
DRNA
1651
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $17.3M | ﹤0.01% |
784,930
+61,805
| +9% | +$1.36M |
|
1652
Dynatrace
DT
$14.8B
| $17.3M | ﹤0.01% |
683,161
+324,561
| +91% | +$8.21M |
|
1653
AtriCure
ATRC
$1.74B
| $17.2M | ﹤0.01% |
530,241
+19,405
| +4% | +$631K |
|
1654
James River Group
JRVR
$244M
| $17.2M | ﹤0.01% |
417,586
+13,490
| +3% | +$556K |
|
1655
Enterprise Financial Services Corp
EFSC
$2.24B
| $17.2M | ﹤0.01% |
356,642
+18,416
| +5% | +$888K |
|
1656
Fate Therapeutics
FATE
$111M
| $17.2M | ﹤0.01% |
876,835
+64,302
| +8% | +$1.26M |
|
|
MDP
1657
DELISTED
Meredith Corporation
MDP
| $17.1M | ﹤0.01% |
528,121
+16,507
| +3% | +$536K |
|
|
FBC
1658
DELISTED
Flagstar Bancorp, Inc. New
FBC
| $17.1M | ﹤0.01% |
447,228
+83,911
| +23% | +$3.21M |
|
1659
Inogen
INGN
$231M
| $17M | ﹤0.01% |
248,913
+5,312
| +2% | +$363K |
|
|
FSCT
1660
DELISTED
ForeScout Technologies, Inc. Common Stock
FSCT
| $17M | ﹤0.01% |
517,471
+16,157
| +3% | +$530K |
|
1661
STAAR Surgical
STAA
$1.37B
| $17M | ﹤0.01% |
482,471
+22,563
| +5% | +$794K |
|
1662
Supernus Pharmaceuticals
SUPN
$2.55B
| $17M | ﹤0.01% |
715,384
+20,299
| +3% | +$481K |
|
1663
ePlus
PLUS
$1.97B
| $16.9M | ﹤0.01% |
401,004
+36,022
| +10% | +$1.52M |
|
1664
Kforce
KFRC
$567M
| $16.9M | ﹤0.01% |
425,624
+235
| +0.1% | +$9.33K |
|
|
TPTX
1665
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $16.9M | ﹤0.01% |
271,255
+124,236
| +85% | +$7.74M |
|
1666
Appian
APPN
$2.28B
| $16.9M | ﹤0.01% |
442,183
+29,271
| +7% | +$1.12M |
|
1667
Granite Construction
GVA
$4.7B
| $16.9M | ﹤0.01% |
609,393
+10,838
| +2% | +$300K |
|
1668
Southside Bancshares
SBSI
$916M
| $16.9M | ﹤0.01% |
453,787
+7,470
| +2% | +$277K |
|
1669
CNA Financial
CNA
$12.9B
| $16.8M | ﹤0.01% |
375,629
-32,443
| -8% | -$1.45M |
|
1670
Addus HomeCare
ADUS
$2.03B
| $16.8M | ﹤0.01% |
172,748
+17,314
| +11% | +$1.68M |
|
1671
MACOM Technology Solutions
MTSI
$9.82B
| $16.8M | ﹤0.01% |
630,992
+23,482
| +4% | +$625K |
|
1672
Oxford Industries
OXM
$701M
| $16.7M | ﹤0.01% |
221,823
+7,353
| +3% | +$555K |
|
|
TWOU
1673
DELISTED
2U, Inc.
TWOU
| $16.7M | ﹤0.01% |
23,188
+1,152
| +5% | +$829K |
|
|
NP
1674
DELISTED
Neenah, Inc. Common Stock
NP
| $16.6M | ﹤0.01% |
235,651
+20,167
| +9% | +$1.42M |
|
1675
Strategy Inc Common Stock Class A
MSTR
$94B
| $16.6M | ﹤0.01% |
1,163,160
+34,720
| +3% | +$495K |
|